(Reuters) -Pharma firm Indivior said on Monday it would cancel its secondary listing on the London Stock Exchange, effective July 25, maintaining its primary listing on the Nasdaq to reduce costs and ...

The pharma group's exit comes after a slew of companies departed the London Stock Exchange over the last few years.

Home-grown start-up Mirxes is going places, but co-founder is firmly rooted in Singapore. Read more at straitstimes.com. Read ...

A wave of listings by Chinese companies is expected to reinvigorate trading activity in Hong Kong, with optimism growing that ...